behaelterbau

Stirring tank

Stirring and mixing tank for all processes

Manufacturing small and medium-sized stirring and process tanks in both sterile and non-sterile versions is one of our company’s strengths. If you have a problem, we'll find the solution! We offer comprehensive support based on years of experience and numerous successful projects. We develop the optimum concept for your system or tank. We manufacture using stainless steel - tanks from 3 l to 5,000 l contents for pharmaceutical use. Our stirring tanks are used by renowned, leading pharmaceutical companies, producers of generic medicines and subcontractors in the pharmaceutical, cosmetic, chemical and food processing industries, ensuring process safety and reproducibility. Through our innovative engineering and outstanding processing quality, we have established ourselves as a specialist for leading manufacturers and for special applications.
Bild14

Articles in the range Stirring tank

IMG_5121
Biotechnology Chemical industry Pharmaceutical

Process tank for sterile production

Pharmaceutical process tank for the sterile production of serum pursuant to PED 2014/68/EU cat. 4/module G, ATEX Directive 2014/34/EU and MD 2006/42/EU.
Top section as pressure dome cover with welded conical nozzle. Torispherical base design. The tank is equipped with a control system, analysis technology and filter. The tank is equipped with a heating/cooling jacket and insulation cover.
Equipment also includes:
  • Magnetic stirrer for a viscosity of 250 mPas
  • Filter for sterile filtration
  • pH measurement
  • O² measurement
  • Metaglas sight glass
  • LED sight glass lights
  • D-ended sight glass in casing
  • Rupture disc / safety valve
  • Product tubes
  • CIP-compatible sampling and outlet valve
  • CIP cleaning nozzle
  • ATEX design
  • Control cabinet in line with ATEX
AREA OF APPLICATION:
Industry: Pharmaceutical
Cytostatic drugs, serum production
SIZE:
10l – 800l
OPERATING DATA:
Tank product chamber:
p = -0,5 / +3,5 bar,
t = -10 / +150 °C
Double wall:
p = -0,5 / +4,5 bar,
t = -10 / +150 °C
MATERIAL:
Parts in contact with product 1.4539 , Delta ferrite <1%, with APZ 3.2/3.1 AD 2000, Ra <0.8µm
Request article
Configure article
Schraegblattruehrwerk-und-Eingriffschutzgitter
Cosmetics industry Food industry Pharmaceutical

Stirring tank with angled turbine blade and protective grille

Agitator vessel with inclined blade agitator and mesh guard grille.

Detail view
Pharmaceutical process and filling tank for pharmaceutical tablet production in line with good engineering practice. Upper section with folding dome pressure cover and welded conical nozzle. Torispherical base design. The tank is equipped with a heating/cooling jacket and insulation cover.

Equipment also includes:
  • Top propeller for a viscosity of 500 mPas
  • CIP cleaning nozzle
  • Bottom valve
AREA OF APPLICATION:
Industry: pharmaceutical, food industry
Product: Tablet base
SIZE:
100 l – 800 l
OPERATING DATA:
Tank product chamber:
p = depressurised
t = -10 / +130 °C
Double wall:
p = -1 / +3,5 bar,
t = -10 / +130 °C
MATERIAL:
Parts in contact with product 1.4404/ 1.4435/ 316L , with APZ 3.1 AD 2000, Ra <0.85µm
Request article
Configure article
Bild11
Cosmetics industry Pharmaceutical

120l ATEX stirring tank with control cabinet

Pharmaceutical process tank for coating liquids pursuant to PED 2014/68/EU module G, ATEX Directive 2014/34/EU and MD 2006/42/EU.
Top section as pressure dome cover with welded conical nozzle. Conical base design. The tank is characterised by its low residual stirring volume. This is approx. 1.0l.

The tank is equipped with a heating/cooling jacket and insulation cover.

Equipment also includes:
  • ATEX propeller for a viscosity of 250 mPas
  • Metaglas sight glass
  • LED sight glass lights
  • Rupture disc / safety valve
  • Product tubes
  • CIP cleaning nozzle
  • ATEX design
AREA OF APPLICATION:
Industry: Pharmaceutical
Product: Coating liquids, spraying liquids
SIZE:
10 l – 500 l
OPERATING DATA:
Tank product chamber:
p = -1 / +3 bar,
t = -10 / +150 °C
Double wall:
p = -1 / +3,5 bar,
t = -10 / +150 °C
MATERIAL:
Parts in contact with product 1.4404/ 1.4435/ 316L , with APZ 3.1 AD 2000, Ra <0.3µm
Request article
Configure article
ruehr2
Pharmaceutical

Sterile stirring tank with magnetic stirrer for small batch sizes

Pharmaceutical mixing and process tank pursuant to Pressure Equipment Directive 2014/68/EU based on modules A/G.
Top section as milled, flat pressure dome cover with integrated nozzles. Conical base design.

The tank is equipped with a heating/cooling jacket and insulation cover.

Equipment also includes:
  • Magnetic stirrer as a bottom agitator for a viscosity of 100 mPas
  • Metaglas sight glass
  • LED sight glass lights
  • Rupture disc
  • Product tubes
  • CIP cleaning nozzle
AREA OF APPLICATION:
Industry: Pharmaceutical, sterile production
Product: pharmaceutical formulations
SIZE:
3 l – 100 l
OPERATING DATA:
Tank product chamber:
p = -1 / +10 bar,
t = -10 / +150 °C
Double wall:
p = -1 / +3,5 bar,
t = -10 / +150 °C
MATERIAL:
Parts in contact with product 316L , with APZ 3.1 AD 2000, Ra <0.5µm
Request article
Configure article

Company

portfolio

links

Dear Sir or Madam,
Dear Mr Weinert,
27.04.2021


On April 30, 2021, we will open another site at Allergopharma GmbH & Co. KG in Reinbek to support COVID 19 vaccine production in the presence of Federal Minister Spahn and Minister President Günther. We would have been pleased to invite you to this opening.

Unfortunately, this was not possible due to the pandemic.
We would therefore like to take this opportunity to thank you for your extraordinary commitment to supplying equipment at short notice to support vaccine production. Allergopharma, as part of Dermapharm Holding SE, is now a further partner in the Europe-wide production network for the vaccine of BioNTech and Pfizer. This network now comprises more than a dozen important pharmaceutical manufacturers and suppliers. From now on, one of four production steps will take place in Reinbek: the vaccine formulation. This is where our mRNA active ingredient is combined with the lipids. A protective shell is created around the mRNA and the vaccine can reach its target in the body to induce the necessary immune response.


Your company has made a very important contribution to the global pandemic response with great know-how and under incredible time pressure. We would like to express our sincere thanks to you and your team! Without their commitment, the successful completion of the project would not have been possible.
We look forward to working with you in partnership in the future!

Dr. Hans-Georg Feldmeier – CEO Dermapharm SE
Dr. Sierk Poetting – CFO and COO BioNTech SE